Amyotrophic Lateral Sclerosis (ALS) 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for ALS trials.

Effective solutions for advancing ALS research

Given the rapidly progressing nature of amyotrophic lateral sclerosis (ALS) and the lack of effective treatments or cures, the need for new treatment options for this rare disease is urgent. Signant Health can support the drug development process by applying our Signant SmartSignals clinical research solutions as well as scientific expertise to help researchers improve trial outcomes through better data.

Navigate ALS Trial Challenges & Meet Your Goals

  • Improved Patient Experience
  • Expert Clinical Advisory
  • Optimized Endpoint Reliability
  • Agile Randomization & Supply Management
  • Patient-Focused Remote Solutions
  • Digitalize the Process
  • Improved Patient Experience

    Improved Patient Experience

    Reduce burdens for your ALS study participants while simultaneously generating better-quality PRO data. Signant SmartSignals eCOA helps study teams implement PRO assessments electronically so patients can self-report without the burden of travel. Plus, it supports caregiver-assisted completion with built-in attributability features.
     

  • Expert Clinical Advisory

    Expert Clinical Advisory

    With decades of clinical science experience, our ALS research leaders are prepared to serve as an extension of your study team. Rely on our in-house neurology experts to help optimize ALS protocols, implement clinically-appropriate instruments, and oversee data quality from launch through regulatory submission.

     

  • Optimized Endpoint Reliability

    Optimized Endpoint Reliability

    Ensure investigative staff administer and score ClinRO assessments accurately by leveraging our clinician-developed Rater Training system as well as our Blinded Data Analytics solution. We'll train raters and then proactively monitor data as they flow in, providing opportunities to correct errors or other quality indicators before they impact your study data.
     

  • Agile Randomization & Supply Management

    Agile Randomization & Supply Management

    Simplify randomization for multi-arm trial designs and minimize product waste or overages with Signant's agile RTSM solution. We'll help you launch faster, manage mid-study changes with ease, and support trial operations no matter how or where you conduct research.
     

  • Patient-Focused Remote Solutions

    Patient-Focused Remote Solutions

    By integrating Actigraph sensors and wearables with our eCOA solution, you’ll gain continuous, real-time data on each patient’s sleep and activity patterns. This objective data will enhance your understanding of the disease’s and treatment’s impact on a patient’s quality of life.
     

  • Digitalize the Process

    Digitalize the Process

    Each solution and service within our Signant SmartSignals evidence generation platform can be applied to a study independently. However, when combined, they create an intuitive and powerful digital ecosystem for creating and managing complex global studies. Plus, every study is supported by a dedicated team of clinical science and operations experts.
     

Comprehensive ALS experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our ALS trial resources
SOLUTION BROCHURE

ALS Trial Solutions Overview


GET INSIGHTS
VIDEO

ALS Trial Solutions


WATCH [2 MIN]
BROCHURE

CNS Clinical Research Solutions

 
LEARN MORE

Ready to learn more?

Discover how Signant can support your current or upcoming ALS trials.